ALTE
Showing 1 - 25 of 37
Upper Respiratory Tract Infection Trial in Milano (Probiotic supplement, Placebo)
Active, not recruiting
- Upper Respiratory Tract Infection
- Probiotic supplement
- Placebo
-
Milano, ItalyFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Sep 27, 2023
Hepatobiliary Tumor Trial in Naples (Holograms, PDF)
Not yet recruiting
- Hepatobiliary Neoplasm
- Holograms
-
Naples, ItalyFederico II University
Sep 21, 2023
Nasal Obstruction, Bilateral Trial in Lichtenfels, Göttingen, Berlin (Vivaer® ARC Stylus)
Active, not recruiting
- Nasal Obstruction, Bilateral
- Vivaer® ARC Stylus
-
Lichtenfels, Bayern, Germany
- +2 more
Mar 30, 2022
Apparent Life-Threatening Event in Infants Under One Year of Age Trial in France (Blood sample for specific analyzes)
Recruiting
- Apparent Life-Threatening Event in Infants Under One Year of Age
- Blood sample for specific analyzes
-
Besançon, France
- +3 more
Jun 28, 2022
Ovarian Reserve in Younger Newly Diagnosed Lymphomas
Active, not recruiting
- Anaplastic Large Cell Lymphoma
- +4 more
- Laboratory Biomarker Analysis
- Questionnaire Administration
-
Birmingham, Alabama
- +106 more
Jan 11, 2023
Patients With Previously Diagnosed High-Risk Neuroblastoma
Active, not recruiting
- Recurrent Neuroblastoma
- +5 more
- Cytology Specimen Collection Procedure
- +2 more
-
Birmingham, Alabama
- +97 more
Oct 28, 2022
Chemotherapy on Fertility in Osteosarcoma Survivors
Active, not recruiting
- Osteosarcoma
- Biospecimen Collection
- +2 more
-
Birmingham, Alabama
- +98 more
Oct 19, 2022
Associated With Cardiomyopathy and Heart Failure After Cancer
Recruiting
- Hodgkin Lymphoma in Remission
- +6 more
- Assessment of Therapy Complications
- +3 more
-
Birmingham, Alabama
- +78 more
Jan 11, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Worldwide (Carvedilol, Laboratory Biomarker Analysis,
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Carvedilol
- +6 more
-
Birmingham, Alabama
- +90 more
Aug 17, 2022
Apparent Life Threatening Events in Infants
Completed
- ALTE
- Interview
-
Mineola, New YorkWinthrop University Hospital
Feb 4, 2019
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Canada, United States (other, device, behavioral)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Educational Intervention
- +5 more
-
Mobile, Alabama
- +110 more
Jan 30, 2023
Participated in Children's Oncology Group Studies
Recruiting
- Acute Lymphoblastic Leukemia
- +5 more
- Assessment of Therapy Complications
- Questionnaire Administration
-
Birmingham, Alabama
- +163 more
Sep 6, 2022
Cardiovascular Disease in Hodgkin Lymphoma Survivors
Not yet recruiting
- Hodgkin Lymphoma
- +3 more
- Patient Self Reporting
- +2 more
- (no location specified)
Jan 20, 2023
l Testing in Younger Patients With Cancer
Recruiting
- Childhood Malignant Neoplasm
- Cognitive Assessment
- Quality-of-Life Assessment
-
Birmingham, Alabama
- +183 more
Aug 12, 2022
Chronic Health Conditions in Down Syndrome-Associated Acute
Not yet recruiting
- Down Syndrome
- +7 more
- Neurological Assessments
- +3 more
- (no location specified)
Jan 18, 2023
Breast Tumor, Ovary Cancer Trial in Wiesbaden, Berlin, Schwerin (Interventions are self controlled by the patient via a mp3
Terminated
- Breast Neoplasm
- Ovary Cancer
- Interventions are self controlled by the patient via a mp3 player and noise reduction headphones.
-
Wiesbaden, Hessen, Germany
- +2 more
Nov 9, 2021
Identifying Late-Occurring Complications in Childhood Cancer
Recruiting
- Childhood Malignant Neoplasm
- Laboratory Biomarker Analysis
- Questionnaire Administration
-
Birmingham, Alabama
- +155 more
Aug 2, 2021
Naloxone Trial in Asheville (Nalox-comm Training Module, Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for
Enrolling by invitation
- Naloxone
- Nalox-comm Training Module
- Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists
-
Asheville, North CarolinaUniversity of North Carolina at Chapel Hill (Asheville campus)
Aug 3, 2022
CNS Nongerminomatous Germ Cell Tumor, Childhood CNS Germinoma Trial in Worldwide (3-Dimensional Conformal Radiation Therapy,
Active, not recruiting
- Central Nervous System Nongerminomatous Germ Cell Tumor
- Childhood Central Nervous System Germinoma
- 3-Dimensional Conformal Radiation Therapy
- +4 more
-
Birmingham, Alabama
- +166 more
Dec 9, 2021
Obstructive Sleep Apnea Syndrome, Temporomandibular Disorders Trial in Germany (H-MAD with a hinge system according to Herbst)
Recruiting
- Obstructive Sleep Apnea Syndrome
- Temporomandibular Disorders
- H-MAD with a hinge system according to Herbst
-
Frankfurt, Germany
- +8 more
Oct 4, 2021
Desmoplastic/Nodular Medulloblastoma, Medulloblastoma, Medulloblastoma With Extensive Nodularity Trial in Worldwide
Active, not recruiting
- Desmoplastic/Nodular Medulloblastoma
- +4 more
- Carboplatin
- +6 more
-
Birmingham, Alabama
- +172 more
Jan 4, 2022
Crohn's Disease Trial in Worldwide (Guselkumab Dose 1, Guselkumab Dose 2, Guselkumab Dose 3)
Active, not recruiting
- Crohn's Disease
- Guselkumab Dose 1
- +7 more
-
Dothan, Alabama
- +574 more
Jan 31, 2023
Entyvio (Vedolizumab) Long Term Safety Study
Completed
- Ulcerative Colitis and Crohn's Disease
- Vedolizumab
- Other Biologic Agents
-
Birmingham, Alabama
- +286 more
Aug 13, 2021